Section I
431 – 440 of 5064
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Treatment with BRAF/MEK : inhibitors in mutant BRAF V600E papillary craniopharyngioma
- Contribution to journal › Article
-
Mark
Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study
- Contribution to journal › Article
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
- Contribution to journal › Article
-
Mark
Degree of food processing and breast cancer risk : a prospective study in 9 European countries
- Contribution to journal › Article
-
Mark
In vivo MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin
- Contribution to journal › Article
-
Mark
The difficulty of studying the association between pathway delays and survival in cancer - an example from bladder cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
Constitutional Factors and Irradiation as Risk Factors for Thymoma : A European Case–Control Study
- Contribution to journal › Article
-
Mark
Beyond Average : a-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer
- Contribution to journal › Article
-
Mark
A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy
(2024)
- Working paper/Preprint › Preprint in preprint archive
